Novel Variants of ELP2 and PIAS1 in the Interferon Gamma Signaling Pathway Are Associated with Non-Small Cell Lung Cancer Survival.
Yu Chen ZhaoDongfang TangSen YangHongliang LiuSheng LuoThomas E StinchcombeCarolyn GlassLi SuSipeng ShenDavid Chistopher ChristianiWenjie JiaoPublished in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2020)
Once validated, these variants could be useful predictors of NSCLC survival.